Improved HPLC Method for the Determination of Moxifloxacin in Application to a Pharmacokinetics Study in Patients with Infectious Diseases

Table 3

Intraday precision 𝑛=5, 𝑥±𝑠).

Actual concentration (μg/mL)	Determined concentration (μg/mL)	Peak area ratio	RSD (%)
0.05	0.049 ± 0.002	0.129 ± 0.005	4.12
0.5	0.480 ± 0.022	1.442 ± 0.045	3.12
2.5	2.632 ± 0.056	8.007 ± 0.148	1.85